Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis

OBJECTIVES: Major adjuvant therapies (ATs) for resected hepatocellular carcinoma (HCC) include chemotherapy, internal radiation therapy (IRT), interferon therapy (IFNT) and immunotherapy but the optimum regimen remains inconclusive. We aim to compare these therapies in terms of patient survival and...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Zhu, Gui-Qi, Shi, Ke-Qing, Yu, Hua-Jian, He, Sun-Yue, Braddock, Martin, Zhou, Meng-Tao, Chen, Yong-Ping, Zheng, Ming-Hua
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2015
Témata:
Clinical Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4627241/
https://ncbi.nlm.nih.gov/pubmed/26061709
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky